You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: April 7, 2020

DrugPatentWatch Database Preview

BAVENCIO Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BAVENCIO

Patents:	28
Applicants:	1
BLAs:	2
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for BAVENCIO

Recent Clinical Trials for BAVENCIO

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
M.D. Anderson Cancer Center	Phase 1/Phase 2
Southwest Oncology Group	Phase 2
Melanoma and Skin Cancer Trials Limited	Phase 1/Phase 2

See all BAVENCIO clinical trials

Patent Text Search: US Patents for BAVENCIO

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC)	2035-06-26	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	ModernaTX, Inc. (Cambridge, MA)	2035-12-23	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	ModernaTX, Inc. (Cambridge, MA)	2036-05-18	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	Immunomedics, Inc. (Morris Plains, NJ)	2035-06-25	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	ChemoCentryx, Inc. (Mountain View, CA)	2036-06-13	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	LAM Therapeutics, Inc. (Guilford, CT)	2034-11-07	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for BAVENCIO

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	108348607	Start Trial
Australia	2017268397	Start Trial
Portugal	3215158	Start Trial
Japan	2006515892	Start Trial
Mexico	PA04012656	Start Trial
Japan	6447933	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

AstraZeneca

Moodys

Merck

Mallinckrodt

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.